Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry

[1]  Tian-bao Huang,et al.  Pre-treatment red blood cell distribution width as a predictor of clinically significant prostate cancer , 2021, International Urology and Nephrology.

[2]  I. Chetty,et al.  Charlson Comorbidity score influence on prostate cancer survival and radiation-related toxicity. , 2020, The Canadian journal of urology.

[3]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[4]  G. Engström,et al.  The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population , 2019, Scientific Reports.

[5]  S. Egawa,et al.  Red Cell Distribution Width Predicts Prostate-Specific Antigen Response and Survival of Patients With Castration-Resistant Prostate Cancer Treated With Androgen Receptor Axis-Targeted Agents. , 2019, Clinical genitourinary cancer.

[6]  T. Badrick,et al.  Red blood cell distribution width (RDW)—a mechanism for normal variation and changes in pathological states , 2018, Journal of Laboratory and Precision Medicine.

[7]  Xiaohong Li,et al.  Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder , 2018, Medicine.

[8]  Ying Ju,et al.  Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer , 2018, Journal of clinical laboratory analysis.

[9]  M. Życzkowski,et al.  The Relationship Between Red Cell Distribution Width and Cancer‐Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy , 2017, Clinical genitourinary cancer.

[10]  Ronald C. Chen,et al.  Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men , 2018, JAMA oncology.

[11]  M. Nalls,et al.  Association of red cell distribution width with all-cause and cardiovascular-specific mortality in African American and white adults: a prospective cohort study , 2017, Journal of Translational Medicine.

[12]  X. An,et al.  The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China , 2016, Oncotarget.

[13]  Jonathan E. Shoag,et al.  Clinical variability and molecular heterogeneity in prostate cancer , 2016, Asian journal of andrology.

[14]  Du-Ping Huang,et al.  Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients , 2016, Medicine.

[15]  J. Hansen,et al.  Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study , 2015, Haematologica.

[16]  Chien-Feng Li,et al.  The Prognostic Significance of Inflammation-Associated Blood Cell Markers in Patients with Upper Tract Urothelial Carcinoma , 2016, Annals of Surgical Oncology.

[17]  Yan Zhang,et al.  Red Cell Distribution Width Is Associated with Presence, Stage, and Grade in Patients with Renal Cell Carcinoma , 2014, Disease markers.

[18]  E. Barrett-Connor,et al.  Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study , 2014, Journal of the American Heart Association.

[19]  K. Cooney,et al.  Prostate cancer in young men: an important clinical entity , 2014, Nature Reviews Urology.

[20]  S. Albayrak,et al.  Red cell distribution width as a predictor of prostate cancer progression. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[21]  D. Masuya,et al.  Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung Cancer , 2013, PloS one.

[22]  K. Chien,et al.  Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan. , 2010, American journal of epidemiology.

[23]  G. Lippi,et al.  Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. , 2009, Archives of pathology & laboratory medicine.

[24]  Z. Prohászka,et al.  Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. , 2009, American heart journal.

[25]  L. Ferrucci,et al.  Red blood cell distribution width and the risk of death in middle-aged and older adults. , 2009, Archives of internal medicine.

[26]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[27]  D. Michaud,et al.  Chronic inflammation and bladder cancer. , 2007, Urologic oncology.

[28]  D. McMillan,et al.  Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer , 2006, Cancer.

[29]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[30]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.